Slides Airfinity – 5th GLOBAL BIOPHARMA CEO / TOP EXECS VIRTUAL PRESS BRIEFING – COVID-19 (8 December 2020)

Position paper 20 Apr 2026

Advancing GMP inspection reliance – from pilots to practice

Around the world, National Regulatory Agencies (NRAs) face mounting pressure to ensure access to and availability of high-quality medicinal products while confronted with an increasing number of sites to inspect, a demand driven by a need to strengthen supply resilience and manage limited inspection resources. This position paper represents the views of the research-based biopharmaceutical...

WTO 14th Ministerial Conference: An opportunity to address trade, innovation, and health

As WTO Members gather in Yaoundé for the 14th Ministerial Conference (MC14), the meeting comes at a pivotal moment for global trade and health.

Sixth meeting of the open-ended Intergovernmental Working Group (IGWG 6) on the WHO Pandemic Agreement: PABS instrument

On behalf of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), we appreciate the opportunity to contribute to the Sixth Meeting of the Intergovernmental Working Group on the Pandemic Agreement. The innovative pharmaceutical industry is a critical partner in pandemic preparedness and response, through sustained investments in R&D, surveillance, manufacturing capacity, and partnerships that...